IOVA

Iovance Biotherapeutics Inc

Jun 03 • 11:42AM ET

3.97

-0.13 -3.17 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: RCUS TNGX CGON KYMR NUVL RYTM BMRN INCY KRYS LKFT

| Held by: VTI XBI IWM VB VXF IWN IBB VBR SCHA VTWO

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-0.95	Insider Own	13.12%	Shs Outstand	438.11M	Perf Week	-9.15%
Market Cap	1.77B	Forward P/E	-	EPS next Y	-0.31	Insider Trans	0.00%	Shs Float	387.93M	Perf Month	3.12%
Enterprise Value	1.51B	PEG	-	EPS next Q	-0.13	Inst Own	54.46%	Short Float	27.48%	Perf Quarter	-6.81%
Income	-353.86M	P/S	6.21	EPS this Y	49.60%	Inst Trans	1.24%	Short Ratio	6.76	Perf Half Y	78.03%
Sales	285.55M	P/B	2.41	EPS next Y	43.74%	ROA	-37.40%	Short Interest	106.61M	Perf YTD	45.42%
Book/sh	1.65	P/C	5.66	EPS next 5Y	-	ROE	-47.51%	52W High	5.63 -29.48%	Perf Year	118.13%
Cash/sh	0.70	P/FCF	-	EPS past 3/5Y	23.93% 10.23%	ROIC	-46.22%	52W Low	1.66 139.16%	Perf 3Y	-54.89%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	25.04%	Volatility	8.13% 8.13%	Perf 5Y	-77.21%
Dividend TTM	-	EV/Sales	5.28	EPS Y/Y TTM	23.00%	Oper. Margin	-125.41%	ATR (14)	0.28	Perf 10Y	-54.10%
Dividend Ex-Date	-	Quick Ratio	3.15	Sales Y/Y TTM	34.26%	Profit Margin	-123.92%	RSI (14)	53.84	Recom	1.50
Dividend Gr. 3/5Y	- -	Current Ratio	3.60	EPS Q/Q	47.50%	SMA20	4.13%	Beta	0.70	Target Price	8.80
Payout	-	Debt/Eq	0.07	Sales Q/Q	44.82%	SMA50	8.14%	Rel Volume	0.52	Prev Close	4.10
Employees	975	LT Debt/Eq	0.06	Earnings	May 07 BMO	SMA200	37.65%	Avg Volume	15.76M	Price	3.97
IPO	Sep 01, 2009	Option/Short	Yes / Yes	EPS/Sales Surpr.	-23.70% -8.23%	Trades		Volume	3,057,952	Change	-3.17%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)